Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Research

• Publication date

  2009-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-08-2793PMID 19244121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation.

  2010cited by this paper
• NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.

  2008cited by this paper
• IL-27 Suppresses Th2 Cell Development and Th2 Cytokines Production from Polarized Th2 Cells: A Novel Therapeutic Way for Th2-Mediated Allergic Inflammation1

  2007cited by this paper
• The biology and therapeutic potential of interleukin 27

  2007cited by this paper
• Multiple myeloma involving the thyroid cartilage.

  2007cited by this paper
• Recombinant Interleukin-2 Significantly Augments Activity of Rituximab in Human Tumor Xenograft Models of B-cell Non-Hodgkin Lymphoma

  2007cited by this paper
• Augmentation of Antigen-Presenting and Th1-Promoting Functions of Dendritic Cells by WSX-1(IL-27R) Deficiency1

  2007cited by this paper
• IL‐27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1

  2007cited by this paper
• STAT 3-Dependent Mechanism T Cells Partially Through + Activated CD 4 Production Including IL-23-Induced IL-17 on Suppression of Proinflammatory Cytokine T Cells versus + Differentiation on Naive CD 4 Two-Sided Roles of IL-27 : Induction of Th 1

  2006cited by this paper
• Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.

  2006cited by this paper
• Interleukin‐21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma

  2006cited by this paper
• Two-Sided Roles of IL-27: Induction of Th1 Differentiation on Naive CD4+ T Cells versus Suppression of Proinflammatory Cytokine Production Including IL-23-Induced IL-17 on Activated CD4+ T Cells Partially Through STAT3-Dependent Mechanism1

  2006cited by this paper
• Differential Effects of IL-27 on Human B Cell Subsets1

  2006cited by this paper
• Differential effects of IL-27 on human B cell subsets

  2006cited by this paper
• Antiangiogenic and Antitumor Activities of IL-271

  2006cited by this paper
• Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.

  2006cited by this paper
• Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27

  2006cited by this paper
• Interleukin-21 Enhances NK Cell Activation in Response to Antibody-Coated Targets1

  2006cited by this paper
• The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis 1

  2005cited by this paper
• Membranous Glomerulonephritis Development with Th2-Type Immune Deviations in MRL/lpr Mice Deficient for IL-27 Receptor (WSX-1)1

  2005cited by this paper
• Intratumoral Recombinant Human Interleukin-12 Administration in Head and Neck Squamous Cell Carcinoma Patients Modifies Locoregional Lymph Node Architecture and Induces Natural Killer Cell Infiltration in the Primary Tumor

  2005cited by this paper
• Exacerbation of Experimental Allergic Asthma by Augmented Th2 Responses in WSX-1-Deficient Mice1

  2005cited by this paper
• Augmentation of Effector CD8+ T Cell Generation with Enhanced Granzyme B Expression by IL-27 1

  2005cited by this paper
• Expression of IL‐27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals

  2005cited by this paper
• Positive and Negative Regulation of the IL-27 Receptor during Lymphoid Cell Activation1

  2005cited by this paper
• The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity1

  2004cited by this paper
• An Indispensable Role for STAT1 in IL-27-Induced T-bet Expression but Not Proliferation of Naive CD4+ T Cells1

  2004cited by this paper
• IL-27 Mediates Complete Regression of Orthotopic Primary and Metastatic Murine Neuroblastoma Tumors: Role for CD8+ T Cells1

  2004cited by this paper
• Interleukin-12 genetic administration suppressed metastatic liver tumor unsusceptible to CTL.

  2004cited by this paper
• Hyperproduction of Proinflammatory Cytokines by WSX-1-Deficient NKT Cells in Concanavalin A-Induced Hepatitis1

  2004cited by this paper
• Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma

  2004cited by this paper
• IL-27 Signaling Compromises Control of Bacterial Growth in Mycobacteria-Infected Mice1

  2004cited by this paper
• Combination Immunotherapy of B-Cell Non-Hodgkin’s Lymphoma with Rituximab and Interleukin-2

  2004cited by this paper
• Potent Antitumor Activity of Interleukin-27

  2004influential reference
• WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27

  2004influential reference
• IL-27 regulates IL-12 responsiveness of naïve CD4+ T cells through Stat1-dependent and -independent mechanisms

  2003cited by this paper
• WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production.

  2003cited by this paper
• The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection.

  2003cited by this paper
• Cutting edge : Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment

  2003cited by this paper
• Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment1

  2003cited by this paper
• IL-27 and IFN-α Signal via Stat1 and Stat3 and Induce T-Bet and IL-12Rβ2 in Naive T Cells

  2003cited by this paper
• IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells.

  2003cited by this paper
• Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2.

  2003cited by this paper
• Disruption of T helper 2-immune responses in Epstein–Barr virus-induced gene 3-deficient mice

  2002cited by this paper
• Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.

  2002cited by this paper
• IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

  2002cited by this paper
• IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells.

  2002cited by this paper
• Interleukin-12 in anti-tumor immunity and immunotherapy.

  2002cited by this paper
• Interleukin‐2 enhances the natural killer cell response to Herceptin‐coated Her2 / neu‐positive breast cancer cells

  2001cited by this paper
• IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner

  2001cited by this paper
• WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection.

  2001cited by this paper
• Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site

  2001cited by this paper
• IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner

  2000cited by this paper
• Development of Th1-type immune responses requires the type I cytokine receptor TCCR

  2000cited by this paper
• Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.

  1998cited by this paper
• Natural killer (NK) cells as effectors of antibody‐dependent cytotoxicity with chimeric antibodies reactive with human squamous‐cell carcinomas of the head and neck

  1995cited by this paper

• Revisiting the role of IL-27 in obesity-related metabolic diseases: safeguard or perturbation?

  2025cites this paper
• Nanomaterial-Interleukin Combination for Boosting NK Cell-Based Tumor Immunotherapy.

  2025cites this paper
• Dichotomy of IL-27 in tumor immunity.

  2025cites this paper
• Inflammatory, Functional, and Compositional Changes of the Uterine Immune Microenvironment in a Lymphangioleiomyomatosis Mouse Model

  2025cites this paper
• Harnessing IL-27: challenges and potential in cancer immunotherapy

  2025influential citation
• Interleukin-6 Family of Cytokines in Cancers

  2024cites this paper
• Natural killer cells: a future star for immunotherapy of head and neck squamous cell carcinoma

  2024cites this paper
• Novel insights into immune cells modulation of tumor resistance.

  2024cites this paper
• An updated advancement of bifunctional IL-27 in inflammatory autoimmune diseases

  2024cites this paper
• IL-27 in combination with anti-PD-1 can be anti-cancer or pro-cancer.

  2023cites this paper
• Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia

  2023cites this paper
• Determination of Tr1 cell populations correlating with distinct activation states in acute IAV infection.

  2023cites this paper
• Teriflunomide induces Foxp3 expression in murine CD8 + T cells while IL-27 and retinoic acid exert a synergistic effect on the induction of CD39 expression on these cells.

  2023cites this paper
• The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance

  2022cites this paper
• IL‐27 improves adoptive CD8+ T cells’ antitumor activity via enhancing cell survival and memory T cell differentiation

  2022cites this paper
• Biomarker discovery for practice of precision medicine in hypopharyngeal cancer: a theranostic study on response prediction of the key therapeutic agents

  2022cites this paper
• Effect of IL-27, Teriflunomide and Retinoic Acid and Their Combinations on CD4+ T Regulatory T Cells—An In Vitro Study

  2022cites this paper
• The past, present, and future of immunotherapy for bladder tumors

  2022cites this paper
• Effect of IL-27 on activity of bone marrow NK cells of patient with B-chronic lymphocytic leukemia in vitro

  2021cites this paper
• Implications of a ‘Third Signal’ in NK Cells

  2021influential citation
• IL-30† (IL-27A): a familiar stranger in immunity, inflammation, and cancer

  2021cites this paper
• Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy

  2021cites this paper
• Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model

  2020cites this paper
• Role of Cytokines in Tumor Immunity and Immune Tolerance to Cancer

  2020cites this paper
• Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice

  2020cites this paper
• Is AAV-delivered IL-27 a potential immunotherapeutic for cancer?

  2020cites this paper
• Neuroblast senescence in the aged brain augments natural killer cell cytotoxicity leading to impaired neurogenesis and cognition

  2020cites this paper
• IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer

  2020cites this paper
• IL-27 impact on NK cells activity: Implication for a robust anti-tumor response in chronic lymphocytic leukemia.

  2020cites this paper
• IL-27, IL-30, and IL-35: A Cytokine Triumvirate in Cancer

  2019cites this paper
• JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation

  2019cites this paper
• IL-27 promotes NK cell effector functions via Maf-Nrf2 pathway during influenza infection

  2019cites this paper
• Indoleamine-2,3-Dioxygenase in Thyroid Cancer Cells Suppresses Natural Killer Cell Function by Inhibiting NKG2D and NKp46 Expression via STAT Signaling Pathways

  2019cites this paper
• IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells

  2019cites this paper
• Regulatory cytokine function in the respiratory tract

  2019cites this paper
• Correction to: IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells

  2019cites this paper
• Molecular Mechanisms of Protection from Hepatitis C Infection

  2018cites this paper
• Investigation of Interleukin-27 in the Sera of Nonmelanoma Skin Cancer Patients

  2018influential citation
• Distinct Role of IL-27 in Immature and LPS-Induced Mature Dendritic Cell-Mediated Development of CD4+ CD127+3G11+ Regulatory T Cell Subset

  2018cites this paper
• IRAK1 Limits TLR3/4- and IFNAR-Driven IL-27 Production through a STAT1-Dependent Mechanism

  2018cites this paper
• Interleukin-27 is a potential marker for the onset of post-transplant malignancies

  2018cites this paper
• The PD‐L1‐ and IL6‐mediated dampening of the IL27/STAT1 anticancer responses are prevented by α‐PD‐L1 or α‐IL6 antibodies

  2018cites this paper
• IL-27R signalling mediates early viral containment and impacts innate and adaptive immunity after chronic lymphocytic choriomeningitis virus infection

  2018cites this paper
• Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection

  2018cites this paper
• The PD-L 1-and IL 6-mediated dampening of the IL 27 / STAT 1 anticancer responses are prevented by α-PD-L 1 or α-IL 6 antibodies

  2018cites this paper
• Effect of IL­-12 family cytokines on NK92 cells

  2017cites this paper
• Reprogrammed chondrocytes engineered to produce IL-12 provide novel ex vivo immune-gene therapy for cancer.

  2017cites this paper
• Zika Virus Infection Preferentially Counterbalances Human Peripheral Monocyte and/or NK Cell Activity

  2017cites this paper
• Interleukin-27 Enhances the Potential of Reactive Oxygen Species Generation from Monocyte-derived Macrophages and Dendritic cells by Induction of p47phox

  2017cites this paper
• Regulation of NK Cell Activation and Effector Functions by the IL-12 Family of Cytokines: The Case of IL-27

  2017cites this paper
• STATs in NK-Cells: The Good, the Bad, and the Ugly

  2017cites this paper
• Dual Roles of IL-27 in Cancer Biology and Immunotherapy

  2017cites this paper
• Oncostatin M: Potential Implications for Malignancy and Metabolism.

  2017cites this paper
• IL-35 expression is increased in laryngeal squamous cell carcinoma and in the peripheral blood of patients.

  2017cites this paper
• IL-27 in Health and Disease

  2016cites this paper
• Interleukin-27: Biological Properties and Clinical Application

  2016cites this paper
• Interleukin-27 rs153109 polymorphism and the risk of non-small-cell lung cancer in a Chinese population

  2016cites this paper
• Regulation and Immune Function of IL-27.

  2016cites this paper
• Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway

  2016cites this paper
• The IL-12/IL-23 Cytokine Family

  2016cites this paper
• IL-27: A Key Player in Immune Regulation

  2016cites this paper
• IL-27 Concentration in Systemic Circulation and Tumor Micro-Circulation Samples of Sclc and Nsclc Patients; Association with Tumor Size, Histological Type and Presence of Metastases

  2016cites this paper
• IL-27 suppresses SKOV3 cells proliferation by enhancing STAT3 and inhibiting the Akt signal pathway.

  2016cites this paper
• IL‐27 stimulates human NK‐cell effector functions and primes NK cells for IL‐18 responsiveness

  2015cites this paper
• Immunity Cells Shapes Long-Lasting Antiviral T + Cell-Intrinsic gp 130 Signaling on CD 4

  2015cites this paper
• Association between polymorphisms in IL27 gene and renal cell carcinoma

  2015cites this paper
• Potential clinical application of interleukin-27 as an antitumor agent

  2015cites this paper
• The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy.

  2015cites this paper
• [Progress on interleukin-27 in tumor immunity].

  2015cites this paper
• Administration of DNA Encoding the Interleukin‐27 Gene Augments Antitumour Responses through Non‐adaptive Immunity

  2015cites this paper
• Biology of IL-27 and its Role in the Host Immunity against Mycobacterium Tuberculosis

  2015cites this paper
• Cell-Intrinsic gp130 Signaling on CD4+ T Cells Shapes Long-Lasting Antiviral Immunity

  2015cites this paper
• Nucleic Acid Targeting: Towards Personalized Therapy for Head and Neck Cancer

  2015cites this paper
• Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination.

  2014cites this paper
• Immunotherapy in Cancer Treatment

  2014cites this paper
• Interleukin-27: Regulation of Immune Responses and Disease Development by a Pleiotropic Cytokine with Pro- and Anti-inflammatory Properties

  2014cites this paper
• The antitumor potential of Interleukin-27 in prostate cancer

  2013cites this paper
• the Recruitment and Activation of NK and in Antitumor Immunity through Regulating Derived IL-27 - Critical Role of Dendritic Cell

  2013cites this paper
• Concentration of serum interleukin-27 increase in patients with lymph node metastatic gastroesophageal cancer.

  2013cites this paper
• Expression levels of IL-27 and IL-17 in multiple myeloma patients: a higher ratio of IL-27:IL-17 in bone marrow was associated with a superior progression-free survival.

  2013cites this paper
• Microglial Regulation by Astrocytes: Effect on CD40 Surface Expression and Its Consequences for Dendritic Cell Maturation

  2013cites this paper
• A Polyglutamic Acid Motif Confers IL-27 Hydroxyapatite and Bone-Binding Properties

  2013cites this paper
• IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells.

  2013cites this paper
• Rapamycin Augments Human DC IL‐12p70 and IL‐27 Secretion to Promote Allogeneic Type1 Polarization Modulated by NK Cells

  2013cites this paper
• IL-27 in tumor immunity and immunotherapy.

  2013cites this paper
• The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte response.

  2013cites this paper
• This information is current as PropertiesHydroxyapatite and Bone-Binding A Polyglutamic Acid Motif Confers IL-27

  2013cites this paper
• Critical Role of Dendritic Cell–Derived IL-27 in Antitumor Immunity through Regulating the Recruitment and Activation of NK and NKT Cells

  2013cites this paper
• IL-27 Enhances the Expression of TRAIL and TLR3 in Human Melanomas and Inhibits Their Tumor Growth in Cooperation with a TLR3 Agonist Poly(I:C) Partly in a TRAIL-Dependent Manner

  2013cites this paper
• IL-27 promotes nitric oxide production induced by LPS through STAT1, NF-κB and MAPKs.

  2013cites this paper
• The Composite Cytokine p28/Cytokine-Like Factor 1 Sustains B Cell Proliferation and Promotes Plasma Cell Differentiation

  2013cites this paper
• Human TCRγδ+ T cells represent a novel target for IL‐27 activity

  2012cites this paper
• Interleukin-27 and interleukin-12 augment activation of distinct cord blood natural killer cells responses via STAT3 pathways.

  2012cites this paper
• Cardiotrophin-1 determines liver engraftment of syngenic colon carcinoma cells through an immune system-mediated mechanism

  2012cites this paper
• IL-27 Is Elevated in Patients With COPD and Patients With Pulmonary TB and Induces Human Bronchial Epithelial Cells to Produce CXCL10

  2012cites this paper
• IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets

  2011cites this paper
• Development of a murine model of lymph node metastases suitable for immunotoxicity studies.

  2011cites this paper
• Interleukin-28B Acts Synergistically With Cisplatin to Suppress the Growth of Head and Neck Squamous Cell Carcinoma

  2011cites this paper
• RECQL 1 and WRN proteins are potential therapeutic targets in head and neck squamous cell carcinoma

  2011cites this paper
• Interleukin-28 B Acts Synergistically With Cisplatin to Suppress the Growth of Head and Neck Squamous Cell Carcinoma

  2011cites this paper